Hyperthermic intraperitoneal chemotherapy improves survival and prognosis in patients with advanced gastrointestinal malignant ascites: a single-center retrospective clinical study

KE Zhui; GAO Jie; LUO Xinpei; LU Jingyi; ZHANG Zhenshan; GUO Xianling; YUAN Min; LIU Zhuqing; HE Xuemin; XU Qing

doi:10.12289/j.issn.2097-4345.24247

Journal of Tongji University(Medical Science), Volume. 46, Issue 3, 333(2025)

Hyperthermic intraperitoneal chemotherapy improves survival and prognosis in patients with advanced gastrointestinal malignant ascites: a single-center retrospective clinical study

KE Zhui¹, GAO Jie¹, LUO Xinpei¹, LU Jingyi¹, ZHANG Zhenshan², GUO Xianling¹, YUAN Min¹, LIU Zhuqing¹, HE Xuemin¹, and XU Qing^1、*

Author Affiliations

¹Department of Oncology, Tenth People's Hospital, School of Medicine, Tongji University, Shanghai 200072, China

²Department of Oncology, Fudan University Affiliated Tumor Hospital, Shanghai 200032, China

show less

Abstract Get PDF(in Chinese)

Figures & Tables(0)

Tools

Get Citation

Copy Citation Text

KE Zhui, GAO Jie, LUO Xinpei, LU Jingyi, ZHANG Zhenshan, GUO Xianling, YUAN Min, LIU Zhuqing, HE Xuemin, XU Qing. Hyperthermic intraperitoneal chemotherapy improves survival and prognosis in patients with advanced gastrointestinal malignant ascites: a single-center retrospective clinical study[J]. Journal of Tongji University(Medical Science), 2025, 46(3): 333

Download Citation

EndNote(RIS)BibTex Plain Text

Set citation alerts for article

Save article for my favorites

Paper Information

Category:

Received: Jun. 16, 2024

Accepted: Aug. 26, 2025

Published Online: Aug. 26, 2025

The Author Email: XU Qing (xuqingmd@aliyun.com)

DOI:10.12289/j.issn.2097-4345.24247

Topics